Sixty euthymic subjects with DSM-IV bipolar disorder were enrolled in an @-week , double-blind , placebo-controlled , randomized study of WSE ( @ mg/d ) as a procognitive agent added adjunctively to the medications being used as maintenance treatment for bipolar disorder .